CELU - Celularity - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Celularity's activity chart (see below) currently has 17 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60% with an average time for these price targets to be met of 99.6 days.

Most recent stock forecast was given by STEVE BROZAK from WBB on 09-Sep-2025. First documented stock forecast 19-Oct-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Sep-2025

$6

$4.75 (380.00%)

$6

1 years 1 months 15 days ago
(09-Sep-2025)

0/2 (0%)

$3.74 (165.49%)

Hold Since 23-Nov-2021

$10

$8.75 (700.00%)

$50

3 years 8 months 24 days ago
(29-Jan-2023)

2/4 (50%)

$0.96 (10.62%)

103

Buy Since 22-Jun-2022

$2.5

$1.25 (100.00%)

$150

3 years 8 months 24 days ago
(29-Jan-2023)

1/2 (50%)

$-6.54 (-72.35%)

232

Buy Since 26-Jan-2022

$100

3 years 10 months 2 days ago
(21-Dec-2022)

2/2 (100%)

$11.2 (12.61%)

27

$6

$4.75 (380.00%)

$100

4 years 2 months 1 days ago
(23-Aug-2022)

4/4 (100%)

$-20.3 (-77.19%)

136

Show more analysts

Please expand the browser size to see the chart

What is CELU (Celularity) average time for price targets to be met?

On average it took 100 days for the stock forecasts to be reached, with an average price target met ratio of 60%.

Which analyst most recently updated their price target on CELU (Celularity)?

Stephen Brozak

Which analyst has the current lower performing score on CELU (Celularity) with a proven track record?

STEPHEN BROZAK

Which analyst has the most public recommendations on CELU (Celularity)?

Stephen Brozak works at WBB and has 2 price targets and 2 ratings on CELU

Which analyst is the currently most bullish on CELU (Celularity)?

Jeffrey Hung with the highest potential upside of $8.75

Which analyst is the currently most reserved on CELU (Celularity)?

Matthew Biegler with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?